Today, the FDA issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act. All five warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions.
Read more: FDA Warns Companies Illegally Selling CBD Products